Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has multiple attached files:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6959352
Reference Type
Journal Article
Title
Environmental phthalate exposure and preterm birth in the PROTECT birth cohort
Author(s)
Ferguson, KK; Rosen, EM; Rosario, Z; Feric, Z; Calafat, AM; Mcelrath, TF; Vega, CV; Cordero, JF; Alshawabkeh, A; Meeker, JD
Year
2019
Is Peer Reviewed?
1
Journal
Environment International
ISSN:
0160-4120
EISSN:
1873-6750
Publisher
Elsevier Ltd
Location
OXFORD
Volume
132
Page Numbers
105099
Language
English
PMID
31430608
DOI
10.1016/j.envint.2019.105099
Web of Science Id
WOS:000493552400057
URL
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070701472&doi=10.1016%2fj.envint.2019.105099&partnerID=40&md5=08dd23754a257a40173b8bd358ed7498
Exit
Abstract
Background: Preterm birth is a global public health issue and rates in Puerto Rico are consistently among the highest in the USA. Exposures to environmental contaminants might be a contributing factor.
Methods: In a preliminary analysis from the Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) cohort (n = 1090), we investigated the association between urinary phthalate metabolite concentrations measured at three study visits (targeted at 20, 24, and 28 weeks of gestation) individually and averaged over pregnancy with gestational age at delivery and preterm birth. We additionally assessed differences in associations by study visit and among preterm births with a spontaneous delivery.
Results: Compared to women in the general USA population, urinary concentrations of metabolites of di-n-butyl phthalate (DBP) and di-isobutyl phthalate (DiBP) were higher among pregnant women in Puerto Rico. Interquartile range (IQR) increases in pregnancy-averages of urinary metabolites of DBP and DiBP were associated with shorter duration of gestation and increased odds of preterm birth. An IQR increase in mono-n-butyl phthalate (MBP), a metabolite of DBP, was associated with 1.55 days shorter gestation (95% confidence interval [CI] = −2.68, −0.42) and an odds ratio (OR) of 1.42 (95% confidence interval [CI]: 1.07, 1.88) for preterm birth. An IQR increase in mono-isobutyl phthalate (MiBP), a metabolite of DiBP, was associated with 1.16 days shorter gestation (95% CI = −2.25, −0.08) and an OR of 1.32 (95% CI: 1.02, 1.71) for preterm birth. Associations were greatest in magnitude for urinary concentrations measured at the second study visit (median 23 weeks gestation). DiBP metabolite associations were greatest in magnitude in models of spontaneous preterm birth. No associations were detected with other phthalate metabolites, including those of di-2-ethylhexyl phthalate.
Conclusion: Among pregnant women in the PROTECT cohort, DBP and DiBP metabolites were associated with increased odds of preterm birth. These exposures may be contributing to elevated rates of preterm birth observed in Puerto Rico.
Keywords
phthalates; preterm birth; gestational age; Puerto Rico; superfund
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity